AVNS icon

Avanos Medical

11.52 USD
-0.08
0.69%
Updated Aug 26, 11:28 AM EDT
1 day
-0.69%
5 days
1.14%
1 month
-4.08%
3 months
-10.00%
6 months
-26.25%
Year to date
-27.23%
1 year
-51.33%
5 years
-63.89%
10 years
-62.14%
 

About: Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Employees: 2,227

0
Funds holding %
of 7,431 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

48% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 64

34% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 29

2% more funds holding

Funds holding: 274 [Q1] → 280 (+6) [Q2]

2.13% more ownership

Funds ownership: 94.35% [Q1] → 96.49% (+2.13%) [Q2]

12% less capital invested

Capital invested by funds: $623M [Q1] → $546M (-$77.1M) [Q2]

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $273K

Research analyst outlook

We haven’t received any recent analyst ratings for AVNS.

Financial journalist opinion

Based on 7 articles about AVNS published over the past 30 days

Negative
Zacks Investment Research
2 weeks ago
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
Neutral
Seeking Alpha
2 weeks ago
Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript
Avanos Medical, Inc. (NYSE:AVNS ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants David C. Pacitti - Chief Executive Officer Jason M.
Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript
Neutral
The Motley Fool
2 weeks ago
Avanos Medical (AVNS) Q2 Revenue Up 2%
Avanos Medical (AVNS) Q2 Revenue Up 2%
Avanos Medical (AVNS) Q2 Revenue Up 2%
Negative
Zacks Investment Research
3 weeks ago
Avanos Medical (AVNS) Misses Q2 Earnings Estimates
Avanos Medical (AVNS) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.34 per share a year ago.
Avanos Medical (AVNS) Misses Q2 Earnings Estimates
Neutral
PRNewsWire
3 weeks ago
Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors
ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice president, chief financial officer, effective Aug. 1, 2025.
Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors
Neutral
PRNewsWire
3 weeks ago
Avanos Medical, Inc. Announces Second Quarter 2025 Results
ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2025 financial results.
Avanos Medical, Inc. Announces Second Quarter 2025 Results
Neutral
PRNewsWire
3 weeks ago
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical
ALPHARETTA, Ga. , July 31, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), announced today the divestiture of its Hyaluronic Acid (HA) product line to Channel-Markers Medical, LLC (CMM), a privately held company based in Raleigh, NC.
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical
Neutral
PRNewsWire
1 month ago
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
ALPHARETTA, Ga. , July 24, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on Tuesday, Aug. 5, at 9 a.m.
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
Negative
Zacks Investment Research
1 month ago
New Strong Sell Stocks for July 15th
DDD, AVNS and BABA have been added to the Zacks Rank #5 (Strong Sell) List on July 15, 2025.
New Strong Sell Stocks for July 15th
Neutral
PRNewsWire
2 months ago
Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer
ALPHARETTA, Ga. , June 9, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the appointment of Camille Chang Gilmore as senior vice president and chief human resources officer.
Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer
Charts implemented using Lightweight Charts™